Colestipol and cholestyramine resin. Comparative effects in familial type II hyperlipoproteinemia.
D000704:Analysis of Variance; D001647:Bile Acids and Salts / Q000378:metabolism*; D001796:Blood Protein Disorders / Q000188:drug therapy* / Q000235:genetics / Q000628:therapy; D002784:Cholesterol / Q000097:blood; D002792:Cholestyramine Resin / Q000494:pharmacology / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004035:Diet Therapy; D004988:Ethers, Cyclic / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006949:Hyperlipidemias / Q000188:drug therapy* / Q000628:therapy; D007475:Ion Exchange Resins / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood*; D008297:Male; D010919:Placebos; D011073:Polyamines / Q000627:therapeutic use*; D013997:Time Factors; D014280:Triglycerides / Q000097:blood
D001647:Bile Acids and Salts; D004988:Ethers, Cyclic; D007475:Ion Exchange Resins; D008074:Lipoproteins; D010919:Placebos; D011073:Polyamines; D014280:Triglycerides; D002792:Cholestyramine Resin; D002784:Cholesterol